- August 7, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
ADVERTISEMENT
Brand Name :
Atrovent, Atrovent HFA
Synonyms :
Class :
Anticholinergic Agent
Dosage Forms and Strengths:
Aerosol Solution, Inhalation
17 mcg/actuation (12.9 g)
Solution, Inhalation
0.02% (2.5 ml)
chronic obstructive pulmonary disease (COPD)
Inhaler:
2
actuations
every 6 hrs
Do not exceed 12 actuations per day
Nebulizer: 2.5 mL every 6-8hours
(Off-label):
Inhaler: 8 actuation every 20min as needed for 3 hours
Nebulizer: 500 mcg every 20min three doses for 1 hour, then as needed
Dosage Forms and Strengths:
Aerosol Solution, Inhalation
17 mcg/actuation (12.9 g)
Solution, Inhalation
0.02% (2.5 ml)
(Off-label):
According to NIH asthma guidelines
Age: <5 years: 2 inhalations every 20min for 1 hour
Age: 5-12 years: 4-8 actuations every 20 min for about 3 hours as needed
Age: ≥12 years: 8 actuation every 20 min for about 3 hours as needed
Age: <5 years: 0.25 mg every 20min for 1 hour
Age: 5-12 years: 250-500 mcg every 20 min for 1 hour 3 doses, then as needed
Age: ≥12 years: 500 mcg every 20 min for 1 hour 3 doses, then as needed
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may have an increased anticholinergic effect when combined with anticholinergic agents
may have an increased anticholinergic effect when combined with anticholinergic agents
may have an increased anticholinergic effect when combined with anticholinergic agents
may have an increased anticholinergic effect when combined with anticholinergic agents
may have an increased anticholinergic effect when combined with anticholinergic agents
may increase the anti-cholinergic effect
may enhance the adverse/toxic effect of loxapine
hydrocodone/chlorpheniramine/pseudoephedrine
may increase the CNS depressant activity of CNS depressants
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect of anti-cholinergic agents
may increase the anticholinergic of anticholinergic agents
may increase the anticholinergic effect of Anticholinergic Agents
may increase the anticholinergic effect of Anticholinergic Agents
may have an increased risk of adverse effects when combined with ipratropium
may have an increased risk of adverse effects when combined with ipratropium
Adverse drug reactions:
Frequency defined
>10%
Chronic obstructive pulmonary disease exacerbation
Bronchitis
1-10%
Dyspnea
Dizziness
Nausea
Urinary tract infection
Headache
Flulike symptoms
Back pain
Cough
Dyspepsia
Dry mouth
Frequency Not Defined
Hypotension
Palpitations
tachycardia
Dry throat
throat irritation
Constipation
Stomatitis
mouth edema
Pregnancy warnings:
Pregnancy Category: not assigned
Breastfeeding warnings:
The release of the drug into the human breastmilk is unknown
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits
Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: ipratropium (Rx)
Pronunciation: IP-ra-TROE-pee-um
Why do we use ipratropium?
Ipratropium is an Anticholinergic Agent used to treat COPD, acute asthma exacerbation, and emphysema.
ADVERTISEMENT
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
